COSCIENS Biopharma Inc.
CSCI.TO
TSX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -43.45% | -63.62% | -55.43% | -57.38% | -66.43% |
| Total Receivables | -14.80% | 7.26% | -48.97% | -20.35% | 105.39% |
| Inventory | -47.28% | -55.23% | -51.43% | -46.79% | -40.39% |
| Prepaid Expenses | -46.62% | -16.53% | 75.94% | -29.20% | 47,625.00% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -89.95% | -87.44% | -64.33% | -40.44% | -33.64% |
| Total Current Assets | -41.26% | -53.85% | -52.05% | -50.98% | -50.30% |
|
|
|||||
| Total Current Assets | -41.26% | -53.85% | -52.05% | -50.98% | -50.30% |
| Net Property, Plant & Equipment | -19.90% | -13.28% | -10.58% | -16.22% | -5.01% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 56.06% | 57.81% | 1.63% | -93.17% | -93.41% |
| Total Assets | -31.60% | -39.50% | -38.89% | -45.49% | -44.93% |
|
|
|||||
| Total Accounts Payable | -65.08% | -79.20% | -69.05% | -57.01% | -57.18% |
| Total Accrued Expenses | -82.72% | -82.55% | -52.00% | -63.95% | -32.00% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -10.53% | -26.48% | -20.66% | -47.65% | -48.65% |
| Total Finance Division Other Current Liabilities | -45.57% | -72.01% | 126.09% | -35.21% | -36.99% |
| Total Other Current Liabilities | -45.57% | -72.01% | 126.09% | -35.21% | -36.99% |
| Total Current Liabilities | -59.84% | -76.13% | -49.97% | -51.23% | -43.65% |
|
|
|||||
| Total Current Liabilities | -59.84% | -76.13% | -49.97% | -51.23% | -43.65% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -13.67% | -6.89% | -5.15% | 61.77% | 60.08% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -4.79% | -10.71% | 1.53% |
| Total Liabilities | -80.41% | -83.23% | -19.72% | -20.95% | -14.09% |
|
|
|||||
| Common Stock & APIC | 0.11% | 0.54% | 0.61% | 1.05% | 2.72% |
| Retained Earnings | 42.22% | 33.46% | -69.35% | -269.29% | -1,223.74% |
| Treasury Stock & Other | 25.87% | 6.49% | -38.03% | -45.91% | -35.96% |
| Total Common Equity | 109.13% | 51.02% | -70.81% | -74.62% | -72.94% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 109.13% | 51.02% | -70.81% | -74.62% | -72.94% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 109.13% | 51.02% | -70.81% | -74.62% | -72.94% |
|
|
|||||